MedWatch

GN Hearing has a long way to go to reach guidance

The hearing aid manufacturer will need to pick up the pace to meet even the lowest end of its 2022 prognosis before time runs out, an analyst assesses.

Photo: Andrew Kelly/Reuters/Ritzau Scanpix

Late on Thursday evening CEST, GN Group lowered its full-year expectations for its GN Audio division – but maintained its prognosis for GN Hearing.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs